Industry News – Infectious Disease – October 14th to November 3rd

In addition to the huge news of an FDA approval of the first treatment for COVID-19 (Gilead Science’s antiviral IV drug remdesivir), we’re looking at the FDA approval of the first treatment for Ebola, as well as a novel microneedle-based skin patch.

November 2, 2020
View the Post

Virtual trials, COVID-19, & the future

As the FDA continues to develop evolving guidelines, our industry has experienced a sudden, paradigm shift towards hybrid and virtual trials, with telemedicine becoming the “norm” for patient interaction across a variety of therapeutic areas.

April 21, 2020
View the Post